IL111144A0 - Pharmaceutical compositions containing amiodarone for the treatment of heart failure - Google Patents
Pharmaceutical compositions containing amiodarone for the treatment of heart failureInfo
- Publication number
- IL111144A0 IL111144A0 IL11114494A IL11114494A IL111144A0 IL 111144 A0 IL111144 A0 IL 111144A0 IL 11114494 A IL11114494 A IL 11114494A IL 11114494 A IL11114494 A IL 11114494A IL 111144 A0 IL111144 A0 IL 111144A0
- Authority
- IL
- Israel
- Prior art keywords
- treatment
- pharmaceutical compositions
- compositions containing
- heart failure
- containing amiodarone
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
- A61K31/7034—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
- A61K31/704—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin attached to a condensed carbocyclic ring system, e.g. sennosides, thiocolchicosides, escin, daunorubicin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
- A61K31/585—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin containing lactone rings, e.g. oxandrolone, bufalin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/55—Protease inhibitors
- A61K38/556—Angiotensin converting enzyme inhibitors
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Molecular Biology (AREA)
- Vascular Medicine (AREA)
- Gastroenterology & Hepatology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP93116013 | 1993-10-04 |
Publications (1)
Publication Number | Publication Date |
---|---|
IL111144A0 true IL111144A0 (en) | 1994-12-29 |
Family
ID=8213319
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IL11114494A IL111144A0 (en) | 1993-10-04 | 1994-10-03 | Pharmaceutical compositions containing amiodarone for the treatment of heart failure |
Country Status (3)
Country | Link |
---|---|
AU (1) | AU7854094A (en) |
IL (1) | IL111144A0 (en) |
WO (1) | WO1995009625A1 (en) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ATE243529T1 (en) * | 1995-02-10 | 2003-07-15 | Searle & Co | COMBINATION OF ACE INHIBITORS WITH ALDOSTERONE ANTAGONISTS FOR THE TREATMENT OF VENTRICULAR HYPERTROPHY |
WO1996024358A1 (en) * | 1995-02-10 | 1996-08-15 | G.D. Searle & Co. | Use of low dose amount of spironolactone for treatment of cardiovascular disease |
FR2735365B1 (en) * | 1995-06-14 | 1997-09-05 | Sanofi Sa | USE OF AN ANGIOTENSIN II ANTAGONIST AND A BENZOFURANE DERIVATIVE FOR THE PREPARATION OF A MEDICAMENT USEFUL IN THE TREATMENT OF CARDIOVASCULAR CONDITIONS |
FR2746013B1 (en) * | 1996-03-18 | 1998-05-29 | Sanofi Sa | USE OF ANTIARRHYTHMIC COMPOUNDS IN THE PREVENTION OF POST INFARCT MORTALITY |
FR2760364A1 (en) * | 1997-03-10 | 1998-09-11 | Sanofi Sa | USE OF ANTIARRHYTHMIC COMPOUNDS FOR REDUCING MORTALITY AFTER MYOCARDIAL INFARCTION |
US6048874A (en) * | 1999-01-26 | 2000-04-11 | Medeva Pharmaceuticals Manufacturing, Inc. | Parenteral metolazone formulations |
CN102423305A (en) * | 2011-12-23 | 2012-04-25 | 中国药科大学 | Isosorbide mononitrate micro-porous osmotic pump tablet and preparation method thereof |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2626176A1 (en) * | 1988-01-25 | 1989-07-28 | Baligadoo Soorianarain | Cardioprotective medicinal preparations comprising amiodarone, a nitro derivative and optionally a beta-blocker |
US4931464A (en) * | 1989-02-15 | 1990-06-05 | E. R. Squibb & Sons, Inc. | Method of reducing pre- and post-ischemic myocardial arrhythmias and fibrillation |
EP0413694B1 (en) * | 1989-02-20 | 1993-05-12 | BALIGADOO, Soorianarain | Cardio-protective drug preparations comprising amiodarone, a nitrate derivate, in particular isosorbide dinitrate and optionally a beta-blocker |
-
1994
- 1994-09-30 AU AU78540/94A patent/AU7854094A/en not_active Abandoned
- 1994-09-30 WO PCT/EP1994/003267 patent/WO1995009625A1/en active Application Filing
- 1994-10-03 IL IL11114494A patent/IL111144A0/en unknown
Also Published As
Publication number | Publication date |
---|---|
WO1995009625A1 (en) | 1995-04-13 |
AU7854094A (en) | 1995-05-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL102571A0 (en) | Pharmaceutical composition for the treatment of heart failure containing an inhibitor of neutral endopeptidase | |
GB2188844B (en) | Pharmaceutical composition for the treatment of psoriasis | |
GB8900678D0 (en) | Compositions for the prevention and medical treatment of parodonthopathy | |
GB2311940B (en) | Pharmaceutical compositions for the treatment of rhinitis | |
AU1430492A (en) | Pharmaceutical composition for the treatment of gastritis | |
IL106521A0 (en) | Pharmaceutical composition for the treatment or prevention of elevated intraocular pressure | |
IL88207A0 (en) | Imidazole compounds and pharmaceutical compositions for the treatment of osteoporosis | |
IL111144A0 (en) | Pharmaceutical compositions containing amiodarone for the treatment of heart failure | |
AP9300581A0 (en) | Benzofuran derivatives processes for their preparation and pharmaceutical compositions containing them and their medical use | |
IL104409A0 (en) | Pharmaceutical compositions containing pyridobenzodiazepinones for axial myopia therapy | |
AU7812794A (en) | Pharmaceutical compositions containing n-acetylcarnosine for the treatment of cataract | |
NO934832D0 (en) | Pharmaceutical composition for the prevention or treatment of arterioscerosis | |
GB2162748A (en) | Medicinal composition for the treatment or prevention of acne by oral administration | |
IL105285A0 (en) | Compositions for the treatment of diabetes | |
IL110780A0 (en) | Pharmaceutical compositions containing 1,3-bis(2-carboxy-chromon-5-yloxy)-propan-2-ol for the treatment of the common cold | |
IL99666A0 (en) | Pharmaceutical compositions for the treatment of diabetes | |
IL102895A0 (en) | Pharmaceutical compositions for lowering blood lipid levels | |
IL105690A0 (en) | Pharmaceutical compositions for the treatment of arrhythmia | |
HU9302821D0 (en) | Pharmaceutical compositions containing 3-substituted-2-oxindole-1-carboxamide as medical agent | |
IL109235A0 (en) | Pharmaceutical compositions containing ureido derivatives for the treatment of lentivirus-induced diseases | |
IL96455A0 (en) | Pharmaceutical compositions for the treatment of hsv | |
IL122731A0 (en) | Pharmaceutical compositions for the treatment of arrhythmia | |
IL89057A0 (en) | Pharmaceutical compositions for the treatment of ulcers containing quinoline or benzodiazine derivatives | |
IL106961A0 (en) | Pharmaceutical compositions for treatment of the eyes | |
GB9413939D0 (en) | Pharmaceutical composition for the treatment of chronic skin ulcers |